Anti-MRSA cephems. Part 2: C-7 cinnamic acid derivatives

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Antimicrobial Research

Background:

• Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant global health threat due to its resistance to conventional antibiotics.
• There is an urgent need for novel therapeutic agents to combat MRSA infections.

Purpose of the Study:

• To synthesize and evaluate novel cephalosporin derivatives for their activity against MRSA.
• To identify compounds with potent antimicrobial properties and favorable safety profiles.

Main Methods:

• Synthesis of 45 novel cephalosporin derivatives incorporating unique cinnamic acid moieties at the C-7 position.
• Utilized Heck reaction and nucleophilic aromatic substitution for compound synthesis.
• Evaluated antimicrobial activity using minimum inhibitory concentration (MIC90) and assessed in vivo efficacy and acute toxicity in mouse models.

Main Results:

• The most active compound (41) exhibited a potent MIC90 of 1.0 microg/mL against MRSA.
• Compound 41 demonstrated significant efficacy with a PD50 of 0.8 mg/kg in vivo.
• Compound 14 displayed a favorable safety profile in acute toxicity studies.

Conclusions:

• Novel cephalosporin derivatives possess significant potential as new agents against MRSA.
• Compound 41 is a highly promising candidate for further development in treating MRSA infections.
• The synthetic strategies employed provide a viable route for generating diverse cephalosporin analogs.